 |
 |
|
 |
|
Accession |
Disease |
Description |
Year |
Source |
RNA-Seq |
Count |
Biomarkers |
|
GSE117468 |
Psoriasis |
Lesional and non-lesional skin gene-expression profiles from Phase-3 clinical trials of Brodalumab |
2018 |
Tissue |
N |
565 |
 |
|
GSE117239 |
Psoriasis |
Cellular and Molecular Changes in Psoriasis Lesions Inducedby Ustekinumab: Distinct Differences in Responders vs. Non responders |
2018 |
Tissue |
N |
324 |
|
|
GSE99802 |
Atopic Dermatitis |
Fezakinumab (anti-IL-22) treatment in adults with moderate-to-severe atopic dermatitis |
2017 |
Tissue |
N |
302 |
|
|
GSE65904 |
Melanoma |
Whole-genome expression analysis of melanoma tumor biopsies from a population-based cohort. |
2015 |
Tissue |
N |
214 |
 |
|
GSE106992 |
Psoriasis |
Cellular and Molecular Changes in Psoriasis Lesions Induced by Ustekinumab: Distinct Differences in Responders vs. Non-Responders |
2017 |
Tissue |
N |
192 |
|
|
GSE13355 |
Psoriasis |
Gene expression data of skin from psoriatic patients and normal controls |
2008 |
Tissue |
N |
180 |
|
|
GSE85034 |
Psoriasis |
Shrinking the Psoriasis assessment gap: Early gene-expression profiling accurately predicts response to long-term treatment |
2016 |
Tissue |
N |
179 |
|
|
GSE54456 |
Psoriasis |
Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms |
2014 |
Tissue |
Y |
174 |
|
|
GSE30999 |
Psoriasis |
Expression data from skin biopsy samples from patients with moderate-to-severe psoriasis |
2011 |
Tissue |
N |
170 |
|
|
GSE41664 |
Psoriasis |
Comparison of Gene Expression in Psoriatic Skin from Different Sources |
2012 |
Tissue |
N |
157 |
|
|
GSE63741 |
Psoriasis |
Gene Expression Analyses of Homo sapiens Inflammatory Skin Diseases |
2014 |
Tissue |
N |
150 |
|
|
GSE121212 |
Psoriasis |
Atopic Dermatitis, Psoriasis and healthy control RNA-seq cohort |
2018 |
Tissue |
Y |
147 |
|
|
GSE59455 |
Melanoma |
Whole genome expression data from formalin-fixed parrafin embedded (FFPE) primary and metastatic melanomas |
2014 |
Tissue |
N |
141 |
|
|
GSE58558 |
Atopic Dermatitis |
Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology |
2014 |
Tissue |
N |
109 |
 |
|
GSE136757 |
Psoriasis |
Molecular and Cellular Responses to the TYK2/JAK1 Inhibitor, PF 06700841, Reveal Reduction of Skin Inflammation in Plaque Psoriasis |
2019 |
Tissue |
N |
106 |
|
|
GSE83582 |
Psoriasis |
Inflammatory signals linking inverse, erythrodermic and chronic plaque psoriasis |
2016 |
Tissue |
N |
102 |
|
|
GSE53552 |
Psoriasis |
Gene expression profiling in psoriatic lesional and non-lesional skin [brodalumab treatment] |
2013 |
Tissue |
N |
99 |
|
|
GSE69967 |
Psoriasis |
Pathologic Immune Pathways in Psoriasis are Rapidly Attenuated by Tofacitinib Treatment: A Randomized Phase 2 Study in Patients with Moderate to Severe Psoriasis |
2015 |
Tissue |
N |
95 |
|
|
GSE11903 |
Psoriasis |
Effective treatment of psoriasis with etanercept is linked to suppression of IL17 signaling, not immediate response TNF |
2009 |
Tissue |
N |
89 |
|
|
GSE7553 |
Melanoma |
Metastatic Melanoma (40) ; Primary Melanoma (14) ; Basal cell carcinoma (15) ; Squamous cell carcinoma (11) ; Normal Skin (4) ; others (3) |
2007 |
Tissue |
N |
87 |
|
|
GSE14905 |
Psoriasis |
Type I Interferon: Potential Therapeutic Target for Psoriasis? |
2009 |
Tissue |
N |
82 |
|
|
GSE55201 |
Psoriasis |
Suppression of inflammation in psoriasis blood after IL-17 treatment with ixekizumab |
2014 |
Blood |
N |
81 |
|
|
GSE41663 |
Psoriasis |
Re-analysis by microarray using cDNA target of samples from psoriasis patients enrolled in an etanercept trial |
2012 |
Tissue |
N |
81 |
|
|
GSE22155 |
Melanoma |
Gene Expression Profiling-Based Identification of Molecular Subtypes in Stage IV Melanoma with Different Clinical Outcome |
2010 |
Tissue |
N |
79 |
|
|
GSE153007 |
Atopic Dermatitis |
Genome-Wide Profiling of Lesional and Non-Lesional Skin from Atopic Dermatitis, Psoriasis, and Contact Dermatitis Skin |
2020 |
Tissue |
N |
75 |
|
|
GSE50496 |
Melanoma |
Melanoma brain metastases and matched extracranial metastases |
2013 |
Tissue |
N |
72 |
|
|
GSE57225 |
Psoriasis |
Intra-individual genome expression analysis reveals a specific molecular signature of psoriasis and eczema |
2014 |
Tissue |
N |
62 |
|
|
GSE32407 |
Psoriasis |
A single intradermal injection of IFN-γ induces a psoriasis-like state in both non-lesional psoriatic and healthy skin |
2011 |
Tissue |
N |
60 |
|
|
GSE158448 |
Psoriasis |
Multiple IL-17 family cytokines signaling through IL-17RA drive inflammatory pathways in psoriasis |
2020 |
Tissue |
N |
60 |
|
|
GSE61281 |
Psoriasis |
Human Whole Blood: Psoriatic Arthritis [PsA] vs. Cutaneous Psoriasis Without Arthritis [PsC] vs. Controls |
2014 |
Blood |
N |
52 |
|
|
GSE114729 |
Psoriasis |
Transcriptome analysis of Psoriasis |
2018 |
Tissue |
Y |
51 |
|
|
GSE41662 |
Psoriasis |
Gene expression profiling in psoriatic lesional and non-lesional skin [Set 2] |
2012 |
Tissue |
N |
48 |
|
|
GSE53431 |
Psoriasis |
Narrow-band UVB phototherapy for psoriasis |
2013 |
Tissue |
N |
47 |
|
|
GSE75343 |
Psoriasis |
Molecular and cellular profilling of scalp psoriasis reveals differences and similarities compared to skin psoriasis |
2015 |
Tissue |
N |
45 |
|
|
GSE66511 |
Psoriasis |
Transcriptional Landscape of Psoriasis Identifies the Involvement of IL36 and IL36RN |
2015 |
Tissue |
Y |
36 |
|
|
GSE27887 |
Psoriasis |
Reversal of Atopic Dermatitis with Narrow-Band UVB Phototherapy and Biomarkers for Therapeutic Response |
2011 |
Tissue |
N |
35 |
|
|
GSE78097 |
Psoriasis |
The spectrum of mild-to-severe psoriasis vulgaris is defined by a common activation of IL-17 pathway genes, but with key differences in immune regulatory genes |
2016 |
Tissue |
N |
33 |
|
|
GSE34248 |
Psoriasis |
Gene expression profiling in psoriatic lesional and non-lesional skin [Set 1] |
2012 |
Tissue |
N |
28 |
|
|
GSE67853 |
Psoriasis |
Exploring Molecular Determinants of Disease Progression in Psoriasis by Comparing Different Clinical Subtypes Having Similar Core Transcriptomes |
2015 |
Tissue |
N |
27 |
|
|
GSE6710 |
Psoriasis |
Expression data from human skin biposies (lesional and uninvolved) from psoriatic patients |
2007 |
Tissue |
N |
26 |
|
|
GSE7216 |
Psoriasis |
pretreatment, treatment with IL, TNF, etc. |
2007 |
Tissue |
N |
25 |
|
|
GSE50614 |
Psoriasis |
A Randomized, Placebo-Controlled Study to Evaluate SRT2104, a Selective SIRT1 Activator, in Patients with Moderate to Severe Psoriasis |
2013 |
Tissue |
N |
22 |
|
|
GSE147339 |
Psoriasis |
Inflammasome Signaling and Impaired Vascular Health in Psoriasis |
2020 |
Blood |
Y |
20 |
|
|
GSE18948 |
Psoriasis |
Personalized medicine in psoriasis: developing a genomic classifier to predict histological response to Alefacept |
2009 |
Blood |
N |
16 |
|
|
GSE123786 |
Psoriasis |
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals |
2018 |
Blood |
Y |
16 |
|
|
GSE10434 |
Acne Vulgaris |
Retinoic acid effect on sebocytes and the skin |
2008 |
Tissue |
N |
12 |
|
|
GSE122220 |
Melanoma |
Gene expression profiles of melanoma tumor samples from patients treated with checkpoint inhibitors (human) |
2018 |
Tissue |
N |
10 |
|
|
GSE166388 |
Psoriasis |
Gene expression profile of epidermis from psoriasis lesions and healthy controls |
2021 |
Tissue |
N |
8 |
|
|
GSE47751 |
Psoriasis |
Early tissue responses to etanercept in psoriasis lesions |
2013 |
Tissue |
N |
8 |
|
|
GSE50790 |
Psoriasis |
Gene expression in psoriasis lesions and uninvolved skin |
2013 |
Tissue |
N |
8 |
|
|
GSE2737 |
Psoriasis |
Affected and unaffected skin of 4 psoriatic patients and normal skin of 3 psoriasis free individuals |
2005 |
Tissue |
N |
8 |
|
|
GSE36387 |
Psoriasis |
PSORS2 is due to mutations in CARD14 |
2012 |
Tissue |
N |
6 |
|
|
|
|
|
|
|
|
|